Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

This publication has 40 references indexed in Scilit:

• Innate Immunity to Herpes Simplex Virus Type 2
  Viral Immunology, 2003
• Antibody‐Dependent Cell‐Mediated Cytotoxicity in Cervical Lavage Fluids of Human Immunodeficiency Virus Type 1–Infected Women
  The Journal of Infectious Diseases, 2002
• Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4⁺Lymphocyte Count
  AIDS Research and Human Retroviruses, 2001
• Limited Antibody‐Dependent Cellular Cytotoxicity Antibody Response Induced by a Herpes Simplex Virus Type 2 Subunit Vaccine
  The Journal of Infectious Diseases, 2000
• Antibody-Dependent Cellular Cytotoxicity in HIV Type 1-Infected Patients Receiving VaxSyn, a Recombinant gp160 Envelope Vaccine
  AIDS Research and Human Retroviruses, 1999
• Identification of Cross-Reactive Antigenic Target Regions for HIV Type 1-Specific Antibody-Dependent Cellular Cytotoxicity
  AIDS Research and Human Retroviruses, 1996
• Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children
  Clinical and Experimental Immunology, 1993
• Antibody-dependent cellular cytotoxicity mediated by CD16+ lymphocytes from HIV-seropositive homosexual men
  Clinical Immunology and Immunopathology, 1990
• Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression
  Journal of Clinical Immunology, 1989
• CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS
  The Lancet, 1988